Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
OmniAb, Inc., a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic, a bispecific rat, and OmniClic, a bispecific chicken, designed for discovery of bispecific antibody applications; OmniTaur, which provides unique structural characteristics of cow antibodies for complex targets; and OmniDeep, a suite of in silico, an AI and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California. more
Time Frame | OABI | Sector | S&P500 |
---|---|---|---|
1-Week Return | -5.72% | -2.27% | -0.57% |
1-Month Return | -6.88% | -3.96% | 1.21% |
3-Month Return | -15.96% | -9.7% | 7.57% |
6-Month Return | -10.19% | -3.37% | 11.45% |
1-Year Return | -30.07% | 3.71% | 28.48% |
3-Year Return | -62.1% | 3.8% | 29.52% |
5-Year Return | -61.17% | 39.78% | 90.66% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 18.32M | 23.27M | 34.75M | 59.08M | 34.16M | [{"date":"2019-12-31","value":31.01,"profit":true},{"date":"2020-12-31","value":39.39,"profit":true},{"date":"2021-12-31","value":58.82,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":57.83,"profit":true}] |
Cost of Revenue | - | - | 14.97M | 16.25M | 19.50M | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":76.77,"profit":true},{"date":"2022-12-31","value":83.35,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 18.32M | 23.27M | 19.78M | 42.83M | 34.16M | [{"date":"2019-12-31","value":42.77,"profit":true},{"date":"2020-12-31","value":54.33,"profit":true},{"date":"2021-12-31","value":46.19,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":79.77,"profit":true}] |
Gross Margin | 100.00% | 100.00% | 56.92% | 72.49% | 100.00% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":56.92,"profit":true},{"date":"2022-12-31","value":72.49,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Expenses | 31.34M | 48.89M | 70.36M | 85.72M | 103.58M | [{"date":"2019-12-31","value":30.26,"profit":true},{"date":"2020-12-31","value":47.2,"profit":true},{"date":"2021-12-31","value":67.92,"profit":true},{"date":"2022-12-31","value":82.76,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (13.03M) | (25.62M) | (35.61M) | (26.65M) | (69.42M) | [{"date":"2019-12-31","value":-1302700000,"profit":false},{"date":"2020-12-31","value":-2562300000,"profit":false},{"date":"2021-12-31","value":-3560900000,"profit":false},{"date":"2022-12-31","value":-2664800000,"profit":false},{"date":"2023-12-31","value":-6941900000,"profit":false}] |
Total Non-Operating Income/Expense | 818.00K | 1.89M | 1.25M | 1.17M | 9.52M | [{"date":"2019-12-31","value":8.6,"profit":true},{"date":"2020-12-31","value":19.86,"profit":true},{"date":"2021-12-31","value":13.16,"profit":true},{"date":"2022-12-31","value":12.34,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (13.03M) | (23.73M) | (34.35M) | (26.06M) | (64.36M) | [{"date":"2019-12-31","value":-1302700000,"profit":false},{"date":"2020-12-31","value":-2372800000,"profit":false},{"date":"2021-12-31","value":-3435000000,"profit":false},{"date":"2022-12-31","value":-2606100000,"profit":false},{"date":"2023-12-31","value":-6436300000,"profit":false}] |
Income Taxes | 562.00K | (6.17M) | (7.31M) | (3.73M) | (13.74M) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-1098.04,"profit":false},{"date":"2021-12-31","value":-1300.36,"profit":false},{"date":"2022-12-31","value":-663.17,"profit":false},{"date":"2023-12-31","value":-2445.55,"profit":false}] |
Income After Taxes | (13.59M) | (17.56M) | (27.04M) | (22.33M) | (50.62M) | [{"date":"2019-12-31","value":-1358900000,"profit":false},{"date":"2020-12-31","value":-1755700000,"profit":false},{"date":"2021-12-31","value":-2704200000,"profit":false},{"date":"2022-12-31","value":-2233400000,"profit":false},{"date":"2023-12-31","value":-5061900000,"profit":false}] |
Income From Continuous Operations | (13.59M) | (17.56M) | (27.04M) | (22.33M) | (29.75M) | [{"date":"2019-12-31","value":-1358900000,"profit":false},{"date":"2020-12-31","value":-1755700000,"profit":false},{"date":"2021-12-31","value":-2704200000,"profit":false},{"date":"2022-12-31","value":-2233400000,"profit":false},{"date":"2023-12-31","value":-2974600000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (13.59M) | (17.56M) | (27.04M) | (22.33M) | (50.62M) | [{"date":"2019-12-31","value":-1358900000,"profit":false},{"date":"2020-12-31","value":-1755700000,"profit":false},{"date":"2021-12-31","value":-2704200000,"profit":false},{"date":"2022-12-31","value":-2233400000,"profit":false},{"date":"2023-12-31","value":-5061900000,"profit":false}] |
EPS (Diluted) | - | - | (0.02) | (0.24) | (0.53) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-2,"profit":false},{"date":"2022-12-31","value":-24,"profit":false},{"date":"2023-12-31","value":-53,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
OABI | |
---|---|
Cash Ratio | 4.12 |
Current Ratio | 4.62 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
OABI | |
---|---|
ROA (LTM) | -13.76% |
ROE (LTM) | -20.45% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
OABI | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.12 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.88 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
OABI | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 22.47 |
P/B | 1.57 |
Price/FCF | NM |
EV/R | 20.73 |
EV/Ebitda | NM |
OmniAb Inc. (OABI) share price today is $3.79
Yes, Indians can buy shares of OmniAb Inc. (OABI) on Vested. To buy OmniAb Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in OABI stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of OmniAb Inc. (OABI) via the Vested app. You can start investing in OmniAb Inc. (OABI) with a minimum investment of $1.
You can invest in shares of OmniAb Inc. (OABI) via Vested in three simple steps:
The 52-week high price of OmniAb Inc. (OABI) is $6.71. The 52-week low price of OmniAb Inc. (OABI) is $3.56.
The price-to-earnings (P/E) ratio of OmniAb Inc. (OABI) is
The price-to-book (P/B) ratio of OmniAb Inc. (OABI) is 1.57
The dividend yield of OmniAb Inc. (OABI) is 0.00%
The market capitalization of OmniAb Inc. (OABI) is $490.10M
The stock symbol (or ticker) of OmniAb Inc. is OABI